(KYMR) Kymera Therapeutics - Performance 42.6% in 12m
KYMR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-8.83%
#38 in Peer-Group
Rel. Strength
82.51%
#1300 in Stock-Universe
Total Return 12m
42.55%
#26 in Peer-Group
Total Return 5y
32.65%
#28 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 52.40 USD |
| 52 Week Low | 21.05 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 62.00 |
| Buy/Sell Signal +-5 | -1.52 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: KYMR (42.6%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: KYMR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KYMR
| Total Return (including Dividends) | KYMR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 45.85% | 3.18% | 4.52% |
| 3 Months | 61.20% | 2.36% | 10.25% |
| 12 Months | 42.55% | -10.75% | 14.16% |
| 5 Years | 32.65% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | KYMR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 16.6% | 30.9% | 79.1% |
| 3 Months | 81.1% | 63.2% | 91.7% |
| 12 Months | -43.9% | -83.8% | 44% |
| 5 Years | -28.6% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th97.00 | 41.36% | 39.54% |
| 3 Month | %th92.50 | 57.48% | 46.21% |
| 12 Month | %th87.50 | 59.73% | 24.87% |
| 5 Years | %th86.00 | 77.40% | -31.81% |
FAQs
Does Kymera Therapeutics (KYMR) outperform the market?
Yes,
over the last 12 months KYMR made 42.55%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months KYMR made 61.20%, while XBI made 2.36%.
Performance Comparison KYMR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
KYMR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -7.2% | 41.3% | 7.1% | 28% |
| US NASDAQ 100 | QQQ | -7.8% | 40.3% | 5.6% | 28% |
| German DAX 40 | DAX | -8% | 45.5% | -8.1% | 12% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.5% | 43.3% | 11.1% | 26% |
| Hongkong Hang Seng | HSI | -7.5% | 39% | -10.1% | 7% |
| India NIFTY 50 | INDA | -7.5% | 43.5% | 6.1% | 42% |
| Brasil Bovespa | EWZ | -6.4% | 42.4% | -14.6% | 32% |
KYMR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -8.3% | 39% | 0.8% | 15% |
| Consumer Discretionary | XLY | -6.6% | 44% | 15% | 22% |
| Consumer Staples | XLP | -3.7% | 47.1% | 8.2% | 34% |
| Energy | XLE | -3.8% | 41.3% | 9.7% | 46% |
| Financial | XLF | -6.9% | 43.4% | 3.9% | 15% |
| Health Care | XLV | -6% | 44.2% | 13.8% | 49% |
| Industrial | XLI | -6.7% | 42.7% | 0.3% | 19% |
| Materials | XLB | -5.8% | 43.5% | 6.3% | 39% |
| Real Estate | XLRE | -2.5% | 46.3% | 8.7% | 31% |
| Technology | XLK | -7.9% | 37.4% | 4.9% | 32% |
| Utilities | XLU | -4.8% | 44.9% | 3.4% | 19% |
| Aerospace & Defense | XAR | -9% | 36.2% | -14% | -9% |
| Biotech | XBI | -5.6% | 42.7% | 19.9% | 53% |
| Homebuilder | XHB | -5.8% | 42% | 17.5% | 42% |
| Retail | XRT | -4.9% | 43.7% | 14.5% | 36% |
KYMR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -0.6% | 36.8% | 14.3% | 53% |
| Natural Gas | UNG | -2.9% | 42.4% | 20.5% | 43% |
| Gold | GLD | -1.5% | 47.3% | -13% | 3% |
| Silver | SLV | -3.7% | 38.2% | -11.2% | 21% |
| Copper | CPER | -8% | 37.2% | -11.4% | 27% |
KYMR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -5.4% | 44% | 10.9% | 42% |
| iShares High Yield Corp. Bond | HYG | -5.2% | 44.3% | 7.6% | 32% |